Air Products & Chemicals, Inc. 10-K Summary (Fiscal Year Ended Sept 30, 2008)
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended September 30, 2008. Air Products & Chemicals, Inc. is a global supplier of industrial gases, process and specialty gases, performance materials, and equipment. The Company serves technology, energy, industrial, and healthcare customers in over 40 countries. It is the world's largest supplier of hydrogen and helium.
During fiscal 2008, the Company significantly restructured its portfolio, divesting the Polymer Emulsions business (reported as discontinued operations) and the High Purity Process Chemicals business. The U.S. Healthcare business was also sold and reported as discontinued operations beginning in the fourth quarter. The Company now reports under four segments: Merchant Gases, Tonnage Gases, Electronics and Performance Materials, and Equipment and Energy.
Key Financial Metrics
Revenue and Segment Mix: The filing does not provide total consolidated revenue figures in the text provided, but details the segment contribution percentages for fiscal 2008:
- Merchant Gases: 40.3% of consolidated sales.
- Tonnage Gases: 34.0% of consolidated sales.
- Electronics and Performance Materials: 21.0% of consolidated sales.
- Equipment and Energy: Remaining portion (implied ~5.7%).
Debt and Liquidity: As of September 30, 2008, total consolidated debt was $3,966.8 million. Approximately $451.4 million of this debt is due within the next twelve months.
Research and Development: R&D expenditures were $131 million in fiscal 2008, compared to $129 million in 2007.
Environmental Costs: Environmental charges to income from continuing operations totaled $31 million in fiscal 2008. The accrual for environmental liabilities on the balance sheet was $82.9 million.
Stock Repurchases: The Company repurchased 23.7 million shares at a total cost of $1,850.8 million as of September 30, 2008. In the fourth quarter alone, 2.6 million shares were purchased for $233.2 million.
Material Changes and Developments
- Divestitures: Sold vinyl acetate ethylene polymers joint ventures to Wacker Chemie AG (Jan 2008); completed sale of Polymer Emulsions business (June 2008); sold High Purity Process Chemicals business; sold U.S. Healthcare business locations (Sept/Oct 2008).
- Segment Reclassification: The Chemicals and Healthcare segments were eliminated. Polymer Emulsions is now discontinued; Polyurethane Intermediates (PUI) moved to Tonnage Gases; Europe Healthcare moved to Merchant Gases.
- Backlog Growth: Equipment and Energy backlog increased to $399 million (Sept 30, 2008) from $258 million (Sept 30, 2007). Approximately 76% of the backlog is for cryogenic air separation equipment.
- Energy Costs: The Company experienced significant increases in energy costs in most regions, necessitating price increases for industrial gases.
Outlook, Risks, and Contingencies
Management Commentary and Outlook: Management expects approximately $289 million of the current equipment backlog to be completed in fiscal 2009. The Company anticipates continued investment in growth markets such as semiconductor materials, refinery hydrogen, and natural gas liquefaction.
Key Risks:
- Economic Conditions: Deteriorating economic conditions in the U.S. and globally may negatively impact demand and profitability.
- Energy and Raw Materials: Energy (electricity, natural gas) is the largest cost component. Inability to pass through cost increases or supply interruptions could materially impact results.
- Asset Impairments: Weakening demand or contract terminations could require impairment charges on long-lived assets.
- Regulatory and Environmental: Risks include greenhouse gas regulations, environmental compliance costs, and potential fines. The Company is involved in proceedings under the Superfund law and RCRA.
- Legal Proceedings: The Company is defending against allegations of anticompetitive activities in Brazil and an EPA referral regarding RCRA violations in Texas. Management does not expect these to have a material adverse effect on financial position.
Investor Verification Checklist
- Verify total consolidated revenue and net income figures in the "Selected Financial Data" table (incorporated by reference) to confirm year-over-year growth trends.
- Review the "Management's Discussion and Analysis" (MD&A) for specific details on how energy cost pass-through mechanisms performed in fiscal 2008.
- Confirm the status of the Brazilian antitrust investigation and the Texas EPA/DOJ referral in subsequent filings to assess potential liability.
- Monitor the execution of the $399 million equipment backlog and the timing of revenue recognition for fiscal 2009.
- Assess the impact of the divested businesses (Polymer Emulsions, Healthcare) on future earnings per share and segment margins.